RCEL

#3760
Avita Medical, Inc. Common Stock
5.60 USD
+14.05%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
5.60
5.60
年范围
3.22
10.29
日变化
+14.05%
每月变动
+21.21%
6个月变化
+6.87%
年变化
-35.33%
前一天收盘价
4.91
开盘价
5.60
买价
卖价
最低价
5.60
High
5.60
交易量
22
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 171.54 M
  • Employee 226
  • Founded 1999
  • CEO James Corbett
  • Website www.avitamedical.com
  • Headquarter Delaware, United States
  • FIGI BBG00TD18T43
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-1.98
市销率
1.34

Avita Medical Inc

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East, Africa and Australia.

新闻